1. Home
  2. GNSS vs ONCY Comparison

GNSS vs ONCY Comparison

Compare GNSS & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genasys Inc.

GNSS

Genasys Inc.

SELL

Current Price

$1.32

Market Cap

77.0M

ML Signal

SELL

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$0.49

Market Cap

80.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GNSS
ONCY
Founded
1992
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Pharmaceuticals and Biotechnology
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
77.0M
80.5M
IPO Year
1996
2002

Fundamental Metrics

Financial Performance
Metric
GNSS
ONCY
Price
$1.32
$0.49
Analyst Decision
Strong Buy
Buy
Analyst Count
3
6
Target Price
$3.87
★ $4.16
AVG Volume (30 Days)
66.4K
★ 1.2M
Earning Date
08-13-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 44.44
N/A
EPS
★ N/A
N/A
Revenue
★ $26,306,790.00
N/A
Revenue This Year
$39.82
N/A
Revenue Next Year
$12.95
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 29.50
N/A
52 Week Low
$1.31
$0.44
52 Week High
$2.47
$1.32

Technical Indicators

Market Signals
Indicator
GNSS
ONCY
Relative Strength Index (RSI) 28.75 20.92
Support Level N/A N/A
Resistance Level $1.60 $0.89
Average True Range (ATR) 0.07 0.05
MACD -0.01 -0.01
Stochastic Oscillator 2.13 17.06

Price Performance

Historical Comparison
GNSS
ONCY

About GNSS Genasys Inc.

Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.

Share on Social Networks: